Efficacy and Safety of Roxadustat for Treatment of Anemia in Participants With Lower Risk Myelodysplastic Syndrome With Low Red Blood Cell Transfusion Burden
Public ClinicalTrials.gov record NCT03263091. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Investigating the Efficacy and Safety of Roxadustat (FG-4592) for Treatment of Anemia in Patients With Lower Risk Myelodysplastic Syndrome (MDS) With Low Red Blood Cell (RBC) Transfusion Burden (LTB)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether FG-4592 is safe and effective in the treatment of anemia in participants with lower risk MDS and low red blood cell transfusion burden.
Study identification
- NCT ID
- NCT03263091
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 184 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 28, 2018
- Primary completion
- Mar 8, 2023
- Completion
- Jun 19, 2023
- Last update posted
- Jul 31, 2024
2018 – 2023
United States locations
- U.S. sites
- 30
- U.S. states
- 11
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site | Bakersfield | California | 93309 | — |
| Investigational Site | Beverly Hills | California | 90212 | — |
| Investigational Site | Burbank | California | 90212 | — |
| Investigational Site | Encino | California | 91436 | — |
| Investigational Site | Laguna Hills | California | 92653 | — |
| Investigational Site | Los Angeles | California | 90095 | — |
| Investigational Site | Los Angeles | California | 91326 | — |
| Investigational Site | Oceanside | California | 92056 | — |
| Investigational Site | Pasadena | California | 91105 | — |
| Investigational Site | Santa Maria | California | 93454 | — |
| Investigational Site | Torrance | California | 90505 | — |
| Investigational Site | Valencia | California | 91355 | — |
| Investigational Site | Ventura | California | 93003 | — |
| Investigational Site | Westlake Village | California | 91361 | — |
| Investigational Site | Whittier | California | 90603 | — |
| Investigational Site | Grand Junction | Colorado | 81501 | — |
| Investigational Site | Pembroke Pines | Florida | 33028 | — |
| Investiational Site | Weston | Florida | 33331 | — |
| Investgational site | Atlanta | Georgia | 30322 | — |
| Investigational Site | Augusta | Georgia | 30912 | — |
| Investigational Site | St Louis | Missouri | 63110 | — |
| Investigational Site | Charlotte | North Carolina | 28204 | — |
| Investigational Site | Canton | Ohio | 44718 | — |
| Investigational Site | Cleveland | Ohio | 44111 | — |
| Investigational Site | Cleveland | Ohio | 44195 | — |
| Investigational Site | Mayfield Heights | Ohio | 44124 | — |
| Investigational Site | Philadelphia | Pennsylvania | 19106 | — |
| Investigational Site | Charleston | South Carolina | 29414 | — |
| Investigational Site | Houston | Texas | 77030 | — |
| Investigational Site | Charlottesville | Virginia | 22908 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 94 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03263091, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 31, 2024 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03263091 live on ClinicalTrials.gov.